STEPHEN F GAMBESCIA Inside Source
More state legislators are poised to legalize “recreational” marijuana beyond medical use. Surprisingly, few medical and public health groups and leaders disagree about what is likely to be the next public health crisis.
Though polls show that cannabis use is generally accepted, even for medical and recreational purposes, federal officials still refuse to use it, given its high potential for abuse and lack of medical value. We consider cannabis a Schedule I substance. We have not heard of any national or local surveys to find out what the general public knows about the risks and benefits of chronic marijuana use.
I reviewed the official languages used in the laws, constitutional amendments, and voter initiatives of 33 states and found that these state legislatures used the quality of patient care and quality of care as the basis for legalizing medical marijuana. We checked how they described the range. Quality markers of patient care were whether the treatment was (a) safe, (b) effective, © evidence-based, (d) standard (e) patient-centred. We found that their language did not guarantee quality patient care, except for the last indicator, patient-centredness.
People are also reading…
You should know that medical marijuana laws were enacted out of compassion for people suffering from diseases and conditions such as cancer, PTSD, Alzheimer’s, and AIDS. It is titled ‘Care Laws with Care’. It’s understandably unpopular to speak out against anything that can help alleviate or calm the conditions and ailments that plague people, but that doesn’t mean there is no medical authority to support its widespread use, and drug control. The fact remains that the federal agency responsible for Concerns about the hazards of this material.
The accelerating movement to “normalize” cannabis use is based not on biomedical evidence but on sociocultural movements, where the risks outweigh the benefits. The “fight to normalize marijuana use” has been with us for decades and rages on, but public information about its use, whether good, bad or indifferent No, almost never.
For example, an approximately eight-year and five-month review of the health section of The Philadelphia Inquirer found that of the 444 issues reviewed, only 19 had articles on the health risks or benefits of cannabis use. I understand. Of all articles published in the United States, he addressed cannabis use to readers of this media market, which is the fourth largest media market for him, in only half of 1%.
Furthermore, it would be naive to expect this nascent industry to act responsibly to “control” the substance, especially in relation to its use by minors. Years of experience with adolescents ingesting the forbidden fruit (tobacco, alcohol, e-cigarettes) and knowing that public health and school systems are no match for the marketing tactics of these disease industries. increase.
Just by looking at cannabis retailer names like Curaleaf, Restore, Remedies, Beyond Hello, and more, the promise of “health” has already begun. The tagline accompanies the marketing efforts to sell these products, with the gentle message of don’t worry about being happy, with actual remedies that heal (what’s bothering you). Get ready for newspapers, billboards, radio ads, teasers at public transport stops, full-page ads at trade shows. Used as intended, cannabis consumption becomes society’s new panacea.
In the future, public health and healthcare advocates will blame corporations, given that marijuana on a large scale has poisoned our people. Before Congress, investors, marketers and cottage industry retailers push people into the marijuana swamp, the next public health challenge in this country will be Crisis can be avoided.
If “following science” is the new mantra of rational and responsible public health and healthcare policy, if legislators normalize marijuana use among us, leaders of health-related organizations simply don’t make money. Why not challenge the people who are chasing them? Country. The normalization of the marijuana movement has successfully followed science.
Stephen F. Gambescia is Professor of Health Services Management at Drexel University.he wrote this InsideSources.com.
It would be naive to expect this fledgling industry to act responsibly to “control” its substances, especially in relation to their use by minors. With decades of experience with alcohol, vaping, we know that public health and school systems are no match for the marketing tactics of these disease industries.